530 related articles for article (PubMed ID: 22653439)
1. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion.
Kang HM; Chung EJ; Kim YM; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):501-8. PubMed ID: 22653439
[TBL] [Abstract][Full Text] [Related]
2. Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion.
Kang JW; Lee H; Chung H; Kim HC
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1413-21. PubMed ID: 24577742
[TBL] [Abstract][Full Text] [Related]
3. Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion.
Shin HJ; Chung H; Kim HC
Acta Ophthalmol; 2011 Feb; 89(1):e35-40. PubMed ID: 21155986
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
[TBL] [Abstract][Full Text] [Related]
5. Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion.
Wolf-Schnurrbusch UE; Ghanem R; Rothenbuehler SP; Enzmann V; Framme C; Wolf S
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3334-7. PubMed ID: 21087958
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
[TBL] [Abstract][Full Text] [Related]
7. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
[TBL] [Abstract][Full Text] [Related]
8. Optical Coherence Tomography Biomarkers Predicting Visual Acuity Change after Intravitreal Bevacizumab Injections for Macular Edema Secondary to Branch Retinal Vein Occlusion.
Segal O; Yavnieli R; Mimouni M; Rabina G; Geffen N; Moisseiev E; Nemet AY
Ophthalmologica; 2022; 245(1):19-24. PubMed ID: 34510041
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
Kim M; Jeong S; Sagong M
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
[TBL] [Abstract][Full Text] [Related]
10. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion.
Terao R; Yuda K; Kure K; Inoue T; Ohtsu H; Yanagi Y
Jpn J Ophthalmol; 2014 Mar; 58(2):139-45. PubMed ID: 24402616
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion.
Sen P; Gurudas S; Ramu J; Patrao N; Chandra S; Rasheed R; Nicholson L; Peto T; Sivaprasad S; Hykin P
Ophthalmol Retina; 2021 Nov; 5(11):1115-1124. PubMed ID: 33610836
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab treatment for acute branch retinal vein occlusion accompanied by subretinal hemorrhage.
Zhao L; Li B; Feng K; Han L; Ma Z; Liu Y
Curr Eye Res; 2015 Jul; 40(7):752-6. PubMed ID: 25330134
[TBL] [Abstract][Full Text] [Related]
17. Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusion.
Tilgner E; Dalcegio Favretto M; Tuisl M; Wiedemann P; Rehak M
Acta Ophthalmol; 2017 Nov; 95(7):e592-e596. PubMed ID: 28266152
[TBL] [Abstract][Full Text] [Related]
18. Ranibizumab for serous macular detachment in branch retinal vein occlusions.
Gallego-Pinazo R; Dolz-Marco R; Pardo-López D; Martínez-Castillo S; Lleó-Pérez A; Arévalo JF; Díaz-Llopis M
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):9-14. PubMed ID: 22527327
[TBL] [Abstract][Full Text] [Related]
19. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
Lee KH; Kang EC; Koh HJ
Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
